Biocorrx Inc (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,212 | -3,771 | -4,377 | -5,211 | -3,507 |
| Depreciation Amortization | 1,197 | 844 | 637 | 646 | 647 |
| Accounts receivable | 1 | 35 | -34 | -1 | 0 |
| Other Working Capital | 1,523 | 714 | 578 | 704 | 378 |
| Other Operating Activity | 1,395 | 325 | 1,155 | 324 | 329 |
| Operating Cash Flow | $-1,096 | $-1,853 | $-2,042 | $-3,538 | $-2,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -2 | -9 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -48 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -48 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-50 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,132 | 971 | 775 | 831 | 102 |
| Debt Repayment | -11 | -35 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 915 | 1,250 | 2,250 | N/A |
| Other Financing Activity | -1 | -1 | 0 | 0 | 5 |
| Financing Cash Flow | $1,119 | $1,850 | $2,025 | $3,081 | $107 |
| Beginning Cash Position | 65 | 69 | 86 | 592 | 2,646 |
| End Cash Position | 88 | 65 | 69 | 86 | 592 |
| Net Cash Flow | $23 | $-3 | $-17 | $-506 | $-2,054 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,096 | -1,853 | -2,042 | -3,538 | -2,152 |
| Capital Expenditure | N/A | N/A | N/A | -2 | -9 |
| Free Cash Flow | -1,096 | -1,853 | -2,042 | -3,540 | -2,161 |